Cost-effectiveness of lung transplantation and its evolution: The Portuguese case

European Journal of Health Economics

Volumn 15, Issue 7, 2014, Pages 767-772

  Mendonça, Luis ^a,b   Perelman, Julian ^b   Rodrigues, Vanessa ^c   Fragata, José ^c,d  

^a HOSPITAL DAS FORÇAS ARMADAS   (Portugal)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^c Centro Hospitalar de Lisboa Central ^*  (Portugal)

^d NOVA MEDICAL SCHOOL   (Portugal)

Author keywords

Cost effectiveness; Health technology assessment; Lung transplantation; Portugal; Volume outcome

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; CYSTIC FIBROSIS; FEMALE; FIBROSING ALVEOLITIS; HUMAN; KAPLAN MEIER METHOD; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PORTUGAL; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; SURVIVAL TIME; AGE; COST BENEFIT ANALYSIS; ECONOMICS; EPIDEMIOLOGY; HEALTH CARE COST; HOSPITAL ADMISSION; STATISTICS AND NUMERICAL DATA;

AGE FACTORS; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG TRANSPLANTATION; MALE; PORTUGAL; QUALITY-ADJUSTED LIFE YEARS; WAITING LISTS;

EID: 84906938375     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-013-0522-z     Document Type: Article

References (19)

1. Christie, J.D., Edwards, L.B., Kucheryavaya, A.Y., Benden, C., Dipchand, A.I., Dobbels, F., Kirk, R., Rahmel, A.O., Stehlik, J., Hertz, M.I.: International Society of Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J. Heart Lung Transpl. 31(10), 1073-1086 (2012)
2. Halm, E.A., Lee, C., Chassin, M.R.: Is volume related to outcome in health care? A systematic review and methodological critique of the literature. Ann Int Med 137(6), 511-520 (2002)
3. Neymark, N., Adriaenssen, I., Gorlia, T., Caleo, S., Bolla, M.: Estimating survival gain for economic evaluations with survival time as principal endpoint: a cost-effectiveness analysis of adding early hormonal therapy to radiotherapy in patients with locally advanced prostate cancer. Health Econ. 11(3), 233-248 (2002)
4. Anyanwu, A.C., McGuire, A., Rogers, C.A., Murday, A.J.: An economic evaluation of lung transplantation. J. Thorac. Cardiovasc. Surg. 123(3), 411-420 (2002)
5. Anyanwu, A.C., McGuire, A., Rogers, C.A., Murday, A.J.: Assessment of quality of life in lung transplantation using a simple generic tool. Thorax 56, 218-222 (2001)
6. Administração Central do Sistema de Saúde (ACSS, Central Administration of the Health System): Base de Dados dos Elementos Analíticos. Ministério da Saúde, Administração Central do Sistema de Saúde (2013). http://www.acss.min-saude.pt/bdea/, last Accessed 3rd May 2013
7. Diário da República: Portaria 839-A/2009. Portugal (2009)
8. Infarmed [National Authority of Medicines and Health Products, IP]: Estatîstica do Medicamento 2008 [Drug Statistics 2008], Ministry of Health, Lisbon (2008)
9. Pordata. Base de Dados Portugal Contemporâneo [Database Contemporary Portugal]. http://www.pordata.pt/Portugal/Ambiente+de+Consulta/ Tabela, last Accessed 3rd May 2013
10. Silva, E.A., Pinto, C.G., Sampaio, C., Pereira, J.A., Drummond, M., Trindade, R.: Orientações metodológicas para estudos de avaliação económica de medicamentos. Infarmed, Ministry of Health, Lisbon (1998)
11. Andronis, L., Barton, P., Bryan, S.: Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making. Prepress Projects (2009)
12. Latimer, N.: NICE DSU Technical Support Document 14: Survival Analysis for Economic Evaluations Alongside Clinical Trials-Extrapolation With Patient-Level Data. Report by the Decision Support Unit. School of Health and Related Research. University of Sheffield, UK (2013)
13. Organization for Economic Cooperation and Development. OECD.StatExtracts. http://stats.oecd.org/Index.aspx?DataSetCode=CPL, last seen on 5th April 2013
14. XE Currency converter, http://www.xe.com/currencyconverter/, last seen on 5th April 2013
15. Groen, H., van der Bij, W., Koeter, G.H., Tenverget, E.M.: Cost-effectiveness of lung transplantation in relation to type of endstage pulmonary disease. Am. J. Transpl. 4, 1155-1162 (2004)
16. Vasiliadis, H.M., Collet, J.P., Penrod, J.R., Ferraro, P., Poirier, C.A.: Cost-effectiveness and cost-utility study of lung transplantation. J. Heart Lung Transpl. 24(9), 1275-1283 (2005)
17. NICE guide to the methods of health technology appraisal. London: NICE (2013)
18. National Institute for Health and Clinical Excellence. Appraising life-extending, end of life treatments. January 2009. http://www.nice.org.uk/ media/88A/F2/SupplementaryAdviceTACEoL.pdf, last Accessed 28th May (2013)
19. Glanville, A.R., Estenne, M.: Indications, patient selection and timing of referral for lung transplantation. Eur. Respir. J. 22(5), 845-852 (2003)